<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>gene therapy immunotherapy &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/gene-therapy-immunotherapy/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Wed, 02 Jul 2025 19:03:50 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>gene therapy immunotherapy &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Engineered Cellular Communication Enhances CAR-T Therapy Effectiveness Against Glioblastoma</title>
		<link>https://bioengineer.org/engineered-cellular-communication-enhances-car-t-therapy-effectiveness-against-glioblastoma/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Wed, 02 Jul 2025 19:03:50 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[CAR-T therapy glioblastoma]]></category>
		<category><![CDATA[cytokine delivery tumors]]></category>
		<category><![CDATA[engineered cellular communication]]></category>
		<category><![CDATA[gene therapy immunotherapy]]></category>
		<category><![CDATA[Tumor microenvironment reprogramming]]></category>
		<guid isPermaLink="false">https://bioengineer.org/engineered-cellular-communication-enhances-car-t-therapy-effectiveness-against-glioblastoma/</guid>

					<description><![CDATA[A groundbreaking advancement in the fight against glioblastoma, one of the deadliest and most treatment-resistant brain tumors, has emerged from researchers at the San Raffaele-Telethon Institute for Gene Therapy (SR-TIGET) in Milan. This multidisciplinary team, led by Nadia Coltella and Luigi Naldini, has devised an innovative gene therapy strategy designed to restore and enhance the [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">251193</post-id>	</item>
	</channel>
</rss>
